Genito Urinary System And Sex Hormones
Signati kicks off trial investigating quicker vasectomy device
Signati Medical has enrolled the first patient in a clinical trial investigating its device designed to quicken vasectomy procedures. The…
Affluent implants artificial sphincter in urinary incontinence study
French company Affluent Medical has completed the first successful implantation of its Artus device for the treatment of urinary incontinence.…
SeaStar’s device granted humanitarian exemption approval for children with AKI
Following positive clinical results, the US Food Drug Administration (FDA) has granted SeaStar Medical a humanitarian device exemption (HDE) approval…
Travere signs $120m licencing deal with Renalys for sparsentan in Asia
Travere Therapeutics has signed a licencing agreement for sparsentan with Japan-based Renalys Pharma for multiple Asian countries. As per the…
Vera’s Phase IIb OLE trial gives extra confidence for Phase III IgAN trial
Vera Therapeutics has said that Phase II open-label expansion (OLE) study data gives extra confidence in the ongoing Phase III…
UroMems hits trial success for automated urinary sphincter implant
UroMems has reached another checkpoint in bringing the first automated artificial urinary sphincter to market after the company announced its…
Calliditas starts Phase II trial for rare kidney disease therapy
Calliditas Therapeutics has initiated a Phase II trial to evaluate setanaxib as a treatment for Alport syndrome. The randomised, placebo-controlled…
Pipeline Moves: Approval prospects rise for oesophageal cancer drug after trial completion
This week on Pipeline Moves, we kickoff by looking at the completion of a Phase III trial in oesophageal cancer.…
Novartis’ atrasentan shows superiority in Phase III IgAN trial
Novartis has reported positive topline data from an ongoing Phase III trial investigating atrasentan in patients with IgA nephropathy (IgAN).…
Omeros’ narsoplimab fails Phase III kidney disease trial
Omeros Coroporation’s narsoplimab has failed to produce positive results in an interim analysis of a Phase III trial investigating its…
